Gossamer Bio, Inc. (GOSS) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Gossamer Bio, Inc. (GOSS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $80.6M, listed on NASDAQ, employing roughly 144 people, carrying a beta of 2.15 to the broader market. Gossamer Bio, Inc. Led by Faheem Hasnain, public since 2019-02-08.

Snapshot as of May 15, 2026.

Spot Price
$0.33
Total OI
75.3K

Learn how max pain is reported and how to read the data →